News | January 22, 2015

Study Documents Pain, Magnet Displacement in Patients With Cochlear Implants

Data demonstrates significant proportion of patients experienced discomfort or pain during MRI process

MRI systems, Cochlear Implants, JAMA Otolaryngology-Head & Neck Surgery

January 22, 2015 — Pain, discomfort and magnet displacement were documented in a small medical records review study of patients with cochlear implants (CIs) who underwent magnetic resonance imaging (MRI), according to a report published online by JAMA Otolaryngology-Head & Neck Surgery.

Undergoing MRI can pose concerns for patients with CI because of exposure of the internal magnet to a strong electromagnetic field. There have been previous reports of adverse events, according to background in the study.

Bo Gyung Kim, M.D., Ph.D., of the Soonchunhyang University College of Medicine, South Korea, and co-authors reviewed the medical records of 18 patients with CIs who had MRIs between 2003 and 2014 at a single center. Of the patients, 16 underwent MRI in a 1.5-T scanner and two patients had an MRI in a 3.0-T scanner. The MRIs included 12 brain scans and 18 scans of other areas of the body.

Of the 18 patients, 13 completed their MRI scan without complications (25 of 30 scans). Five patients fitted with protective head bandages could not complete their MRI because of pain: one of these patients experienced magnet displacement. Another patient tolerated the pain and discomfort of her third MRI scan, despite having gauze bandages, but experienced magnet polarity reversal. The two patients that underwent 3.0-T MRI scanning did so without bandaging and experienced no adverse events or complications (one patient had an MRI of the knee and the other patient, who had an MRI of the shoulder, did report some discomfort). Hearing-related performance was unaffected in three CI patients who had major adverse events associated with MRI scanning.

"In the present study, however, we found that seven of the 13 patients who had not undergone general anesthesia (seven of 19 MRI scans) experienced discomfort or pain during the MRI scans. One patient who had undergone general anesthesia was awakened by pain during the MRI scan and could not complete the MRI. Our data clearly demonstrate that a significant proportion of patients experienced discomfort or pain during the MRI process and were unable to complete the scans. Therefore, in addition to device safety and image quality, patient comfort should be considered when performing MRI procedures," the authors note.

For more information: http://media.jamanetwork.com

 

 

Related Content

ADHD Medication May Affect Brain Development in Children

Images of regions of interest (colored lines) in the white matter skeleton representation. Data from left and right anterior thalamic radiation (ATR) were averaged. Image courtesy of C. Bouziane et al.

News | Neuro Imaging | August 16, 2019
A drug used to treat attention-deficit/hyperactivity disorder (ADHD) appears to affect development of the brain’s...
Profound Medical Receives U.S. FDA 510(k) Clearance for Tulsa-Pro
Technology | Interventional Radiology | August 16, 2019
Profound Medical Corp. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to...
Synaptive Medical Launches Modus Plan With Automated Tractography Segmentation
Technology | Neuro Imaging | August 07, 2019
Synaptive Medical announced the U.S. launch and availability of Modus Plan featuring BrightMatter AutoSeg. This release...
Canon Medical Introduces Encore Orian MR Upgrade Program
News | Magnetic Resonance Imaging (MRI) | August 06, 2019
Canon Medical Systems USA Inc. is helping to provide low-cost patient care solutions for its customers with the launch...
FDA Issues Draft Guidance on Medical Device Safety in MRI Environment
News | Magnetic Resonance Imaging (MRI) | August 01, 2019 | Jeff Zagoudis, Associate Editor
The U.S. Food and Drug Administration (FDA) issued a new draft guidance titled Testing and Labeling Medical Devices for...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...